Answers are grounded in this paper and cite their sources.
Tuberculosis (TB) is a significant public health challenge, with the elderly population being particularly affected in certain regions. Around 17.5% of TB cases in France, in 2019, occurred in individuals over 65 years old. Aging leads to decreased lung function and structural changes that predispose the elderly to TB infection. Immunosenescence, comorbidities, malnutrition, and communal living situations increase TB risk in the elderly. TB symptoms in the elderly are often nonspecific and overlap with other conditions, complicating diagnosis. Radiological presentations may differ from younger patients, and the elderly may struggle to produce sputum for testing. Elderly patients may experience varying tolerances to TB medications, and age-related physiological changes and comorbidities influence treatment tolerance and outcomes. Careful management of drug interactions is crucial. Elderly TB patients, especially those who are frail or dependent, are at higher risk for infection and complications. Adherence to treatment is critical, often necessitating directly observed therapy and nutritional support.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: